LillyPad, Our Company Blog: Improving Lives, Improving Lilly – Shared Value in Action

September 14, 2011 | By: David Marbaugh

You may have seen me or Rob Smith blogging about shared value and how it’s the wave of the future for corporate responsibility. And you may have thought, “OK, Sounds good. But why the heck do they keep going on about it?”

Well, here’s why: On September 13 we announced The Lilly NCD Partnership, a new program we’ve been developing for almost a year that epitomizes shared value. Lilly is investing $30 million over five years to fight the rising burden of non-communicable diseases in developing countries – diseases such as diabetes, cancer and cardiovascular diseases. Our initial focus will be on diabetes, an area in which there is great global need for new approaches – and in which we have over 80 years of experience, knowledge and passion.

We are partnering with leading global health organizations to identify comprehensive new approaches to improving diabetes care for people who often go untreated or don’t receive proper treatment for a myriad of reasons. With our partners, we will research and test new models of patient care; report the results of these pilots—including what worked and what didn’t; and advocate for the adoption and replication of the best, most cost-effective solutions. This comprehensive approach will help inform decisions by the global health community, including governments and key stakeholders, on how best to invest limited resources to address diabetes in underserved populations.

In the end, it’s about improving individual people’s lives, which has ripple effects on families, communities, nations and, dare we hope, even the world. 

And it’s about making Lilly a better company. Throughout this partnership, we will have our eyes, ears and minds open – looking for new ways to do things, new ways to meet people’s needs, new ways of working with others who are looking for solutions.

To learn more, you can read our press release and I encourage you to watch this short video. 

And watch LillyPad, our company blog – you can be sure we’ll keep going on and on about this exciting new program.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com

LILLY16749